Depressive Symptoms in Asymptomatic Stage B Heart Failure with Type II Diabetic Mellitus

Overview

Journal Clin Cardiol

Specialty Cardiology & Vascular Diseases

Date 2019 Apr 25

PMID 31017303

Citations 5

Authors

Paul J Mills

Pam R Taub

Ottar Lunde

Meredith A Pung

Kathleen Wilson

Christopher Pruitt

Thomas Rutledge

Alan Maisel

Barry H Greenberg

Affiliations

Soon will be listed here.

Abstract

Background: The presence of concomitant Type II diabetic mellitus (T2DM) and depressive symptoms adversely affects individuals with symptomatic heart failure (HF).

Hypothesis: In presymptomatic stage B HF, this study hypothesized the presence of greater inflammation and depressive symptoms in T2DM as compared to non-T2DM Stage B patients.

Methods: This cross-sectional study examined clinical parameters, inflammatory biomarkers, and depressive symptoms in 349 T2DM and non-T2DM men with asymptomatic stage B HF (mean age 66.4 years ±10.1; range 30-91).

Results: Fewer diabetic HF patients had left ventricular (LV) systolic dysfunction (P < .05) although more had LV diastolic dysfunction (P < .001). A higher percentage of T2DM HF patients were taking ACE-inhibitors, beta-blockers, calcium channel blockers, statins, and diuretics (P values < .05). T2DM HF patients had higher circulating levels of interleukin-6 (IL-6) (P < .01), tumor necrosis factor-alpha (P < .01), and soluble ST2 (sST2) (P < .01) and reported more somatic/affective depressive symptoms (Beck Depression Inventory II) (P < .05) but not cognitive/affective depressive symptoms (P = .20). Among all patients, in a multiple regression analysis predicting presence of somatic/affective depressive symptoms, sST2 (P = .026), IL-6 (P = .010), B-type natriuretic peptide (P = .016), and sleep (Pittsburgh Sleep Quality Index [P < .001]) were significant predictors (overall model F = 15.39, P < .001, adjusted R = .207).

Conclusions: Somatic/affective but not cognitive/affective depressive symptoms are elevated in asymptomatic HF patients with T2DM patients. Linkages with elevated inflammatory and cardiac relevant biomarkers suggest shared pathophysiological mechanisms among T2DM HF patients with somatic depression, and these conditions are responsive to routine interventions, including behavioral. Copyright © 2019 John Wiley & Sons, Ltd.

Citing Articles

Development and Challenges of Pre-Heart Failure with Preserved Ejection Fraction.

Dong G Rev Cardiovasc Med. 2024; 24(9):274.

PMID: 39076392 PMC: 11270127. DOI: 10.31083/j.rcm2409274.

Digestive Enzyme Activity and Protein Degradation in Plasma of Heart Failure Patients.

Courelli V, Ahmad A, Ghassemian M, Pruitt C, Mills P, Schmid-Schonbein G Cell Mol Bioeng. 2021; 14(6):583-596.

PMID: 34900012 PMC: 8630255. DOI: 10.1007/s12195-021-00693-w.

Greater Well-Being in More Physically Active Cancer Patients Who Are Enrolled in Supportive Care Services.

Tristao Parra M, Esmeaeli N, Kohn J, Henry B, Klagholz S, Jain S Integr Cancer Ther. 2020; 19:1534735420921439.

PMID: 32456467 PMC: 7265567. DOI: 10.1177/1534735420921439.

Is Belonging to a Religious Organization Enough? Differences in Religious Affiliation Versus Self-ratings of Spirituality on Behavioral and Psychological Variables in Individuals with Heart Failure.

Saiz J, Pung M, Wilson K, Pruitt C, Rutledge T, Redwine L Healthcare (Basel). 2020; 8(2).

PMID: 32397220 PMC: 7349115. DOI: 10.3390/healthcare8020129.

Depressive symptoms in asymptomatic stage B heart failure with Type II diabetic mellitus.

Mills P, Taub P, Lunde O, Pung M, Wilson K, Pruitt C Clin Cardiol. 2019; 42(6):637-643.

PMID: 31017303 PMC: 6553353. DOI: 10.1002/clc.23187.

References

Roy T, Lloyd C . Epidemiology of depression and diabetes: a systematic review. J Affect Disord. 2012; 142 Suppl:S8-21. DOI: 10.1016/S0165-0327(12)70004-6. View

de Miranda Azevedo R, Roest A, Hoen P, de Jonge P . Cognitive/affective and somatic/affective symptoms of depression in patients with heart disease and their association with cardiovascular prognosis: a meta-analysis. Psychol Med. 2014; 44(13):2689-703. DOI: 10.1017/S0033291714000063. View

Jimenez J, Redwine L, Rutledge T, Dimsdale J, Pung M, Ziegler M . Depression ratings and antidepressant use among outpatient heart failure patients: implications for the screening and treatment of depression. Int J Psychiatry Med. 2013; 44(4):315-34. DOI: 10.2190/PM.44.4.c. View

Mills P, Taub P, Lunde O, Pung M, Wilson K, Pruitt C . Depressive symptoms in asymptomatic stage B heart failure with Type II diabetic mellitus. Clin Cardiol. 2019; 42(6):637-643. PMC: 6553353. DOI: 10.1002/clc.23187. View

Delisle V, Arthurs E, Abbey S, Grace S, Stewart D, Steele R . Symptom reporting on the Beck Depression Inventory among post-myocardial infarction patients: in-hospital versus follow-up assessments. J Psychosom Res. 2012; 73(5):356-61. DOI: 10.1016/j.jpsychores.2012.08.021. View

Levinger I, Selig S, Jerums G, Stewart A, Gaskin C, Hare D . Depressed mood, glycaemic control and functional capacity in overweight/obese men with and without type 2 diabetes. Diabetol Metab Syndr. 2012; 4(1):46. PMC: 3520815. DOI: 10.1186/1758-5996-4-46. View

Hwang B, Moser D, Pelter M, Nesbitt T, Dracup K . Changes in Depressive Symptoms and Mortality in Patients With Heart Failure: Effects of Cognitive-Affective and Somatic Symptoms. Psychosom Med. 2015; 77(7):798-807. PMC: 4565732. DOI: 10.1097/PSY.0000000000000221. View

van Dijk S, Adriaanse M, van der Zwaan L, Bosmans J, van Marwijk H, Van Tulder M . Measurement properties of depression questionnaires in patients with diabetes: a systematic review. Qual Life Res. 2018; 27(6):1415-1430. PMC: 5951879. DOI: 10.1007/s11136-018-1782-y. View

Mills P, Dimsdale J, Natarajan L, Ziegler M, Maisel A, Greenberg B . Sleep and health-related quality of life in heart failure. Congest Heart Fail. 2009; 15(5):228-33. PMC: 2921834. DOI: 10.1111/j.1751-7133.2009.00106.x. View

10.

Downs C, Faulkner M . Toxic stress, inflammation and symptomatology of chronic complications in diabetes. World J Diabetes. 2015; 6(4):554-65. PMC: 4434076. DOI: 10.4239/wjd.v6.i4.554. View

11.

Ammar K, Jacobsen S, Mahoney D, Kors J, Redfield M, Burnett Jr J . Prevalence and prognostic significance of heart failure stages: application of the American College of Cardiology/American Heart Association heart failure staging criteria in the community. Circulation. 2007; 115(12):1563-70. DOI: 10.1161/CIRCULATIONAHA.106.666818. View

12.

Williams L, Nye B, Wende A . Diabetes-Related Cardiac Dysfunction. Endocrinol Metab (Seoul). 2017; 32(2):171-179. PMC: 5503861. DOI: 10.3803/EnM.2017.32.2.171. View

13.

OKeeffe S, Lye M, Donnellan C, Carmichael D . Reproducibility and responsiveness of quality of life assessment and six minute walk test in elderly heart failure patients. Heart. 1999; 80(4):377-82. PMC: 1728807. DOI: 10.1136/hrt.80.4.377. View

14.

Lenihan D . Progression of heart failure from AHA/ACC stage A to stage B or even C: can we all agree we should try to prevent this from happening?. J Am Coll Cardiol. 2012; 60(24):2513-4. DOI: 10.1016/j.jacc.2012.08.1005. View

15.

Smarr K, Keefer A . Measures of depression and depressive symptoms: Beck Depression Inventory-II (BDI-II), Center for Epidemiologic Studies Depression Scale (CES-D), Geriatric Depression Scale (GDS), Hospital Anxiety and Depression Scale (HADS), and Patient Health.... Arthritis Care Res (Hoboken). 2012; 63 Suppl 11:S454-66. DOI: 10.1002/acr.20556. View

16.

Smyth C . The Pittsburgh Sleep Quality Index (PSQI). Insight. 2002; 25(3):97-8. DOI: 10.1067/min.2000.107649. View

17.

Slavich G, Irwin M . From stress to inflammation and major depressive disorder: a social signal transduction theory of depression. Psychol Bull. 2014; 140(3):774-815. PMC: 4006295. DOI: 10.1037/a0035302. View

18.

Cezaretto A, Ferreira S, Sharma S, Sadeghirad B, Kolahdooz F . Impact of lifestyle interventions on depressive symptoms in individuals at-risk of, or with, type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials. Nutr Metab Cardiovasc Dis. 2016; 26(8):649-62. DOI: 10.1016/j.numecd.2016.04.009. View

19.

De Rosa S, Arcidiacono B, Chiefari E, Brunetti A, Indolfi C, Foti D . Type 2 Diabetes Mellitus and Cardiovascular Disease: Genetic and Epigenetic Links. Front Endocrinol (Lausanne). 2018; 9:2. PMC: 5776102. DOI: 10.3389/fendo.2018.00002. View

20.

Mandviwala T, Khalid U, Deswal A . Obesity and Cardiovascular Disease: a Risk Factor or a Risk Marker?. Curr Atheroscler Rep. 2016; 18(5):21. DOI: 10.1007/s11883-016-0575-4. View